Literature DB >> 2101792

Effects of insulin-like growth factor-I on insulin and glucagon release from isolated perfused rat pancreas.

K Kawai1, S Suzuki, K Takano, N Hizuka, Y Watanabe, K Yamashita.   

Abstract

The infusion of recombinant insulin-like growth factor I (IGF-I) causes a decrease in plasma glucose and insulin. In this study we examined whether or not IGF-I directly affects islet hormone release by means of a rat pancreas perfusion system. A superphysiologic concentration of IGF-I (2 nM) elicited a slight but significant decrease in insulin release under the perfusate glucose concentration of 120 mg/dl. A pharmacological concentration of IGF-I (200 nM) significantly suppressed the increase in insulin release in response to an increase in the perfusate glucose concentration (from 4.5 mM to 12.8 mM), but did not affect the decrease in insulin release in response to a decrease in the perfusate glucose concentration (from 6.9 mM to 2.8 mM). Glucagon release was not influenced by IGF-I in these experiments. These results suggest that IGF-I potentially inhibits the insulin release from islet B-cells directly, but its pathophysiological significance may be slight considering its partial inhibition at superphysiologic concentrations and its stable plasma level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2101792     DOI: 10.1507/endocrj1954.37.867

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  1 in total

1.  A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.

Authors:  M L Hartman; P E Clayton; M L Johnson; A Celniker; A J Perlman; K G Alberti; M O Thorner
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.